Aquilo Capital Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-271,302
| Closed | -$1.94M | – | 11 |
|
|
2025
Q1 | $1.94M | Sell |
271,302
-75,000
| -22% | -$536K | 3.48% | 7 |
|
|
2024
Q4 | $2.68M | Sell |
346,302
-584,406
| -63% | -$4.52M | 4.04% | 7 |
|
|
2024
Q3 | $9.76M | Buy |
930,708
+24,460
| +3% | +$257K | 7.4% | 4 |
|
|
2024
Q2 | $10.6M | Hold |
906,248
| – | – | 10.22% | 4 |
|
|
2024
Q1 | $19.1M | Buy |
906,248
+103,824
| +13% | +$2.19M | 14.31% | 2 |
|
|
2023
Q4 | $14.4M | Sell |
802,424
-45,000
| -5% | -$808K | 8.98% | 6 |
|
|
2023
Q3 | $13.9M | Sell |
847,424
-22,690
| -3% | -$373K | 12.64% | 3 |
|
|
2023
Q2 | $17.4M | Buy |
870,114
+39,100
| +5% | +$782K | 9.64% | 4 |
|
|
2023
Q1 | $15.7M | Sell |
831,014
-66,670
| -7% | -$1.26M | 6.51% | 6 |
|
|
2022
Q4 | $20.4M | Sell |
897,684
-70,000
| -7% | -$1.59M | 7.65% | 5 |
|
|
2022
Q3 | $25.6M | Sell |
967,684
-200,000
| -17% | -$5.29M | 9.22% | 5 |
|
|
2022
Q2 | $28.8M | Buy |
1,167,684
+49,000
| +4% | +$1.21M | 9.84% | 5 |
|
|
2022
Q1 | $37.1M | Buy |
1,118,684
+105,088
| +10% | +$3.49M | 5.46% | 5 |
|
|
2021
Q4 | $33.1M | Buy |
1,013,596
+174,457
| +21% | +$5.7M | 3.76% | 5 |
|
|
2021
Q3 | $35.2M | Buy |
839,139
+243,695
| +41% | +$10.2M | 6.39% | 5 |
|
|
2021
Q2 | $23.1M | Buy |
595,444
+36,000
| +6% | +$1.4M | 6.01% | 8 |
|
|
2021
Q1 | $19.1M | Buy |
559,444
+56,000
| +11% | +$1.91M | 3.45% | 9 |
|
|
2020
Q4 | $22.8M | Sell |
503,444
-7,316
| -1% | -$332K | 4.75% | 8 |
|
|
2020
Q3 | $14.1M | Sell |
510,760
-42,693
| -8% | -$1.17M | 1.49% | 8 |
|
|
2020
Q2 | $20.4M | Buy |
553,453
+280,242
| +103% | +$10.3M | 4.11% | 8 |
|
|
2020
Q1 | $8.85M | Buy |
273,211
+4,433
| +2% | +$144K | 3.45% | 11 |
|
|
2019
Q4 | $11M | Buy |
+268,778
| New | +$11M | 4.14% | 9 |
|